2023 Consulting Provider Specialization 
FDA Law Blog
DECEMBER 7, 2023
There were too many interesting panels and discussions to mention them all, but presentations about DOJ’s and FDA’s coordination deserve some special mention. In his conference keynote address , Arun Rao—the Deputy Assistant Attorney General for DOJ’s Consumer Protection Branch—provided an overview of DOJ’s year in FDA enforcement.
The Clinical Problem Solvers
MARCH 14, 2025
Additionally, he consults with federal agencies on mental health system design and practices. Dr. There are a growing number of Child Psychiatric Access Programs, including one in Massachusetts, which provide quick access to psychiatric consultation and facilitates referrals for accessing ongoing behavioral health care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
NOVEMBER 6, 2024
Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023.
PEMBlog
OCTOBER 18, 2024
Duchenne Muscular Dystrophy (DMD) is a complex and progressive disease requiring highly specialized care, especially in emergency situations. Emergency Care Plans and Advanced Directives Many DMD patients will arrive with comprehensive emergency care plans or letters from their providers. Updated 2023 Jul 10]. Pediatrics.
Physician's Weekly
JUNE 19, 2025
On a gloomy Friday in January, Johnson, a nurse practitioner who treats older adults, had a hospice consult with Ellen, a patient in her 90s in declining health. “We step into places where other providers may not, and geriatrics is a prime example of that.” “Hello. How are you feeling?”
FDA Law Blog
JUNE 26, 2023
Houck — The Drug Enforcement Administration (“DEA”) has designated precursor chemicals, including 4-piperidone just last month, used in the illicit manufacture of controlled substances as List I and II chemicals over the years as “laboratory supplies,” but has never revised or updated its Special Surveillance List. 39,479, (June 16, 2023).
Physician's Weekly
JUNE 19, 2025
About 3 in 10 adults reported not taking their medicines as prescribed at some point between July 2022 and July 2023 because of the cost, according to a KFF survey. Like I’m having to go outside of that in order to get them the medications that are nothing special. Bea Bosco is our consulting director of operations.
Expert insights. Personalized for you.
52 
Let's personalize your content